+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Artificial Intelligence in Diagnostics Market By Diagnosis Type (Radiology, Oncology, Neurology, Cardiology, Chest & Lungs, Pathology and Other Diagnosis Types), By Component (Services, Software and Hardware), By Country, Industry Analysis and Forecast, 2020 - 2026

  • PDF Icon

    Report

  • 81 Pages
  • July 2020
  • Region: Europe
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5137601
The Europe Artificial Intelligence in Diagnostics Market is expected to witness market growth of 26.9% CAGR during the forecast period (2020-2026).

Throughout health care, machine vision has demonstrated important use in medicine and in the treatment of a few diseases. Robotic surgery uses machine vision to identify distances or a particular body part. Computer vision applications have accurate diagnostic tests while eliminating false positives. Technology can potentially eliminate the need for redundant surgical procedures and expensive therapies. Computer vision algorithms that are developed using a large amount of training data will predict the slightest appearance of a disease that human doctors can overlook due to their sensory limitations.

NLP is commonly used by the clinical and research community of healthcare to produce and maintain semi-structured and unstructured handwritten records such as electronic health reports, pathology reports, and clinical notes. The algorithm extracts health problems from narrative clinical documents and proposes to be included in the patient's electronic problem list in order to interpret them correctly. Demand for NLP has grown, with healthcare organizations using it to organize and analyze their clinical data more precisely. Furthermore, the increasing use of the Internet and mobile apps, along with the vast volume of patient data, is driving the growth of this industry.

Artificial intelligence (AI) and associated innovations are increasingly widespread in industry and culture and are beginning to be applied to healthcare. New innovations have the ability to change certain areas of health care, as well as administrative processes within providers, insurers, and pharmaceutical organizations.

Based on Diagnosis Type, the market is segmented into Radiology, Oncology, Neurology, Cardiology, Chest & Lungs, Pathology and Other Diagnosis Types. Based on Component, the market is segmented into Services, Software and Hardware. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Siemens AG (Siemens Healthineers), Aidoc Medical Ltd., AliveCor, Inc., Imagen Technologies, Inc., VUNO, Inc., IDx Technologies, Inc., NovaSignal Corporation, Riverain Technologies, LLC, and Zebra Medical Vision Ltd.

Scope of the Study

Market Segmentation:

By Diagnosis Type
  • Radiology
  • Oncology
  • Neurology
  • Cardiology
  • Chest & Lungs
  • Pathology and
  • Other Diagnosis Types

By Component
  • Services
  • Software and
  • Hardware

By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Companies Profiled
  • General Electric (GE) Co. (GE Healthcare)
  • Siemens AG (Siemens Healthineers)
  • Aidoc Medical Ltd.
  • AliveCor, Inc.
  • Imagen Technologies, Inc.
  • VUNO, Inc.
  • IDx Technologies, Inc.
  • NovaSignal Corporation
  • Riverain Technologies, LLC
  • Zebra Medical Vision Ltd.

Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Artificial Intelligence in Diagnostics Market, by Diagnosis Type
1.4.2 Europe Artificial Intelligence in Diagnostics Market, by Component
1.4.3 Europe Artificial Intelligence in Diagnostics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Recent Industry Wide Strategic Developments
3.1.1 Partnerships, Collaborations and Agreements
3.1.2 Product Launches and Product Expansions
3.1.3 Approvals
3.2 Top Winning Strategies
3.2.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.2.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, Nov – 2020, Jun) Leading Players
Chapter 4. Europe Artificial Intelligence in Diagnostics Market by Diagnosis Type
4.1 Europe Radiology Market by Country
4.2 Europe Oncology Market by Country
4.3 Europe Neurology Market by Country
4.4 Europe Cardiology Market by Country
4.5 Europe Chest & Lungs Market by Country
4.6 Europe Pathology Market by Country
4.7 Europe Other Diagnosis Types Market by Country
Chapter 5. Europe Artificial Intelligence in Diagnostics Market by Component
5.1 Europe Services Market by Country
5.2 Europe Software Market by Country
5.3 Europe Hardware Market by Country
Chapter 6. Europe Artificial Intelligence in Diagnostics Market by Country
6.1 Germany Artificial Intelligence in Diagnostics Market
6.1.1 Germany Artificial Intelligence in Diagnostics Market by Diagnosis Type
6.1.2 Germany Artificial Intelligence in Diagnostics Market by Component
6.2 UK Artificial Intelligence in Diagnostics Market
6.2.1 UK Artificial Intelligence in Diagnostics Market by Diagnosis Type
6.2.2 UK Artificial Intelligence in Diagnostics Market by Component
6.3 France Artificial Intelligence in Diagnostics Market
6.3.1 France Artificial Intelligence in Diagnostics Market by Diagnosis Type
6.3.2 France Artificial Intelligence in Diagnostics Market by Component
6.4 Russia Artificial Intelligence in Diagnostics Market
6.4.1 Russia Artificial Intelligence in Diagnostics Market by Diagnosis Type
6.4.2 Russia Artificial Intelligence in Diagnostics Market by Component
6.5 Spain Artificial Intelligence in Diagnostics Market
6.5.1 Spain Artificial Intelligence in Diagnostics Market by Diagnosis Type
6.5.2 Spain Artificial Intelligence in Diagnostics Market by Component
6.6 Italy Artificial Intelligence in Diagnostics Market
6.6.1 Italy Artificial Intelligence in Diagnostics Market by Diagnosis Type
6.6.2 Italy Artificial Intelligence in Diagnostics Market by Component
6.7 Rest of Europe Artificial Intelligence in Diagnostics Market
6.7.1 Rest of Europe Artificial Intelligence in Diagnostics Market by Diagnosis Type
6.7.2 Rest of Europe Artificial Intelligence in Diagnostics Market by Component
Chapter 7. Company Profiles
7.1 General Electric (GE) Co. (GE Healthcare)
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Product Launches and Product Expansions:
7.1.5.3 Approvals:
7.2 Siemens AG (Siemens Healthineers)
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Partnerships, Collaborations, and Agreements:
7.3 Aidoc Medical Ltd.
7.3.1 Company Overview
7.3.2 Recent strategies and developments:
7.3.2.1 Product Launches and Product Expansions:
7.3.2.2 Partnerships, Collaborations, and Agreements:
7.4 AliveCor, Inc.
7.4.1 Company Overview
7.4.2 Recent strategies and developments:
7.4.2.1 Partnerships, Collaborations, and Agreements:
7.4.2.2 Product Launches and Product Expansions:
7.5 Imagen Technologies, Inc.
7.5.1 Company Overview
7.6 VUNO, Inc.
7.6.1 Company Overview
7.6.2 Recent strategies and developments:
7.6.2.1 Approvals:
7.7 IDx Technologies, Inc.
7.7.1 Company overview
7.7.2 Recent strategies and developments:
7.7.2.1 Partnerships, Collaborations, and Agreements:
7.8 NovaSignal Corporation
7.8.1 Company Overview
7.9 Riverain Technologies, LLC
7.9.1 Company Overview
7.10 Zebra Medical Vision Ltd.
7.10.1 Company overview
7.10.2 Recent strategies and developments:
7.10.2.1 Partnerships, Collaborations, and Agreements:
7.10.2.2 Approvals:

Companies Mentioned

  • General Electric (GE) Co. (GE Healthcare)
  • Siemens AG (Siemens Healthineers)
  • Aidoc Medical Ltd.
  • AliveCor, Inc.
  • Imagen Technologies, Inc.
  • VUNO, Inc.
  • IDx Technologies, Inc.
  • NovaSignal Corporation
  • Riverain Technologies, LLC
  • Zebra Medical Vision Ltd.

Methodology

Loading
LOADING...